Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive Analysis and Experimental Validation of HEPACAM2 as a Potential Prognosis Biomarker and Immunotherapy Target in Colorectal Cancer

4 Nov 2024

Abstract excerpt

BACKGROUND: The role of HEPACAM family member 2 (HEPACAM2) is unclear in colorectal cancer (CRC). OBJECTIVE: The objective of this study was to perform an extensive examination of HEPACAM2 and validate it experimentally in CRC. METHODS: This study investigated the significance of HEPACAM2 in CRC and its potential diagnostic utility utilizing data from the Cancer Genome Atlas (TCGA) database. Additionally, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Inflammatory mediators and NSAID effects
Share to Radiopharmaceutical Chemistry and Applications

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39492767
DOI: 10.2174/0115665232325395241018103006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Analysis and Experimental Validation of HEPACAM2 as a Potential Prognosis Biomarker and Immunotherapy Target in Colorectal CancerPMID 39492767Read ↗

Identification and Validation of HEPACAM family member 2 is Correlated with Immune Infiltration as a Prognostic Biomarker in colon adenocarcinomaSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals that FBXO2 as a potential therapeutic target associated with immune infiltrationSemantic proximity Read ↗

A Comprehensive Multi-Omics Analysis Identifies a Robust Scoring System for Cancer-Associated Fibroblasts and Intervention Targets in Colorectal CancerSemantic proximity Read ↗

Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal CancerSemantic proximity Read ↗

Systematic Expression Analysis of the Diagnostic and Prognostic Value of HEPACAM Family Member 2 in Colon AdenocarcinomaSemantic proximity Read ↗

Single‐Cell RNA‐Seq Recognized Key Genes for Metastasis and Macrophage Infiltration in Colorectal CancerSemantic proximity Read ↗

An Update on the Potential Roles of E2F Family Members in Colorectal CancerSemantic proximity Read ↗

A novel prognostic signature of immune‐related genes for patients with colorectal cancerSemantic proximity Read ↗

Development and validation of a prognostic model for colon cancer based on mitotic gene signatures and immune microenvironment analysisSemantic proximity Read ↗

ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing AnalysisSemantic proximity Read ↗

Development and Validation of a Unique Gignature of Cancer Stemness-related Genes for Predicting the Overall survival of Colorectal Cancer PatientsSemantic proximity Read ↗

Bioinformatic Identification of SCP2 as a Novel Prognostic and Immunological Biomarker for Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.